David W. Osborne, Chief Technical Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 856 shares at $16.44 ($14K) on 2022-03-07, disclosed to the SEC on 2022-03-07.
Scheduled sale ($14k) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.86 | 828 | $14K | 96.8% |
| 2 | $16.44 | 28 | $460 | 3.2% |
| Total | $16.85 avg | 856 | $14K | 100% |
| Filing → |
| ARQT | SELL | 2022-07-12 | $112K | — | Filing → |
| ARQT | SELL | 2022-04-21 | $45K | — | Filing → |
| ARQT | SELL | 2022-03-03 | $14K | — | Filing → |